Concourse Financial Group Securities, Inc. Verona Pharma PLC Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

29 transactions

Quarter	Operation	Price Per share
Q2 2025 Aug 12, 2025	BUY	$53.9 - $98.68 $0 - $0
Q1 2025 May 14, 2025	BUY	$44.81 - $69.63 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$28.71 - $47.02 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$15.46 - $30.16 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$11.48 - $17.02 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$15.3 - $20.24 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$11.94 - $20.47 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$16.3 - $22.09 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$16.3 - $22.09 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$19.41 - $23.43 $0 - $0
Q1 2023 May 15, 2023	BUY	$18.06 - $25.27 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$9.84 - $26.13 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$4.14 - $13.59 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$3.55 - $5.06 $0 - $0
Q1 2022 May 09, 2022	BUY	$4.82 - $6.98 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.91 - $7.08 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$5.29 - $6.35 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$5.72 - $9.09 $0 - $0
Q1 2021 May 13, 2021	BUY	$7.08 - $9.33 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$5.51 - $8.11 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$4.45 - $10.2 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$3.6 - $6.12 $0 - $0
Q1 2020 May 13, 2020	BUY	$2.16 - $7.28 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.7 - $6.58 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$4.03 - $5.44 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$5.1 - $6.91 $0 - $0
Q1 2019 May 15, 2019	BUY	$5.52 - $10.0 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$9.0 - $13.47 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$11.65 - $14.1 $0 - $0

Others Institutions Holding VRNA

# of Institutions

293

Shares Held

84.9M

Call Options Held

984K

Put Options Held

3.11M

Perceptive Advisors LLC New York, NY

5.51M
Shares

$589 Million
22.87% of portfolio
Hbk Investments L P Dallas, TX

4.26M
Shares

$456 Million
6.29% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

4.13M
Shares

$441 Million
16.48% of portfolio
Fil LTD Hamilton, D0

3.49M
Shares

$373 Million
0.32% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.38M
Shares

$362 Million
15.27% of portfolio

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $6.52B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account